WHO ICTRP trial
Three-day vs five-day oral prednisolone for acute exacerbation in chronic…
TCTR20200327002 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20200327002 |
|---|---|
| Public title | Three-day vs five-day oral prednisolone for acute exacerbation in chronic obstructive pulmonary disease |
| Scientific title | Three-day vs five-day oral prednisolone for acute exacerbation in chronic obstructive pulmonary disease: A Double-blinded Randomized Non-inferior Controlled Trial. |
| Primary sponsor | khon kaen hospital |
| Secondary sponsors | kamalasai hospital |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | thailand |
| Conditions | We exclude patients who have a history of asthma, ischemic heart disease, radiological diagnosis of pneumonia, congestive heart failure or other lung diseases, history of any cancer disease, pregnancy history of asthma ischemic heart… |
| Interventions | They will treat by dexamethasone 4 mg intravenous q6hr for 24hr then three-day vs five-day oral prednisolone according to tracking number by Intervention group received 0.5 mg. per kilogram of oral prednisone daily for three days, followed… |
| Registration date | Mar 27, 2020 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: